during the fast evolving subject of oncology investigation, precise and successful mutation screening is critical for creating focused therapies. The KRAS products and services Platform performs a pivotal part During this landscape by offering comprehensive remedies for KRAS mutation profiling and Assessment. KRAS mutations, found in roughly 95% of